The aim of this review is to present evidence of the impact of ischemic changes in the blood–
brain barrier on the maturation of post-ischemic brain neurodegeneration with features of …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder caused by the
accumulation of amyloid‐beta (Aβ) proteins and neurofibrillary tangles in the brain. There …

The blood–brain barrier (BBB) is a unique and selective feature of the central nervous
system's vasculature. BBB dysfunction has been observed as an early sign of Alzheimer's …

Huntington's disease (HD) is a currently incurable neurogenerative disorder and is typically
characterized by progressive movement disorder (including chorea), cognitive deficits …

Alzheimer's disease (AD) is a highly prevalent neurodegenerative condition that has
devastating effects on individuals, often resulting in dementia. AD is primarily defined by the …

Adipose tissue has recently been recognized as an important endocrine organ that plays a
crucial role in energy metabolism and in the immune response in many metabolic tissues …

Alzheimer's disease (AD) is the most prevalent cause of dementia characterized by a
progressive cognitive decline. Addressing neuroinflammation represents a promising …

As the globe's population increases, the incidences of Alzheimer's disease (AD) are steadily
increasing. AD represents the most common neurological disorder and constitutes 60–70 …

Due to the complex pathological mechanisms of Alzheimer's disease (AD), its treatment
remains a challenge. One of the major difficulties in treating AD is the difficulty for drugs to …

The blood–brain barrier (BBB) plays a vital role in protecting the central nervous system
(CNS) by preventing the entry of harmful pathogens from the bloodstream. However, this …